111 related articles for article (PubMed ID: 2007454)
1. Role of endogenous platelet-activating factor(PAF) in stress-induced hemorrhagic pancreatitis in rats.
Kimura T; Furukawa M; Arita Y; Takano S; Yamaguchi H; Sumii T; Nawata H
Gastroenterol Jpn; 1991 Feb; 26(1):100. PubMed ID: 2007454
[No Abstract] [Full Text] [Related]
2. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist.
Fujimura K; Kubota Y; Ogura M; Yamaguchi T; Binnaka T; Tani K; Kitagawa S; Mizuno T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):199-202. PubMed ID: 1571504
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.
Yamaguchi Y; Matsumura F; Liang J; Okabe K; Matsuda T; Ohshiro H; Ishihara K; Akizuki E; Yamada S; Ogawa M
Pancreas; 1999 May; 18(4):355-63. PubMed ID: 10231840
[TBL] [Abstract][Full Text] [Related]
4. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.
Konturek SJ; Dembinski A; Konturek PJ; Warzecha Z; Jaworek J; Gustaw P; Tomaszewska R; Stachura J
Gut; 1992 Sep; 33(9):1268-74. PubMed ID: 1385272
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.
Ogura M; Kubota Y; Inoue K
J Gastroenterol; 1996 Jun; 31(3):414-9. PubMed ID: 8726834
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
[TBL] [Abstract][Full Text] [Related]
7. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Zhou WG; Chao W; Levine BA; Olson MS
Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
[TBL] [Abstract][Full Text] [Related]
8. Gastric hemodynamic disturbance induced by hemorrhagic shock in rats. Role of platelet-activating factor.
Binnaka T; Yamaguchi T; Kubota Y; Hirohara J; Mizuno T; Sameshima Y
Scand J Gastroenterol; 1990 Jun; 25(6):555-62. PubMed ID: 2359986
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor mediates pancreatic function derangement in caerulein-induced pancreatitis in rats.
Alonso R; Montero A; Arévalo M; García LJ; Sánchez-Vicente C; Rodríguez-Nodal F; López-Novoa JM; Calvo JJ
Clin Sci (Lond); 1994 Jul; 87(1):85-90. PubMed ID: 7520381
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation.
Zhou W; Levine BA; Olson MS
Am J Pathol; 1993 May; 142(5):1504-12. PubMed ID: 8494049
[TBL] [Abstract][Full Text] [Related]
11. Effects of the platelet-activating factor antagonists CV-6209 and CV-3988 on nephrotoxic serum nephritis in the rat.
Iida H; Fujita M; Izumino K; Asaka M; Entani C; Takata M; Sasayama S
Nephron; 1992; 60(4):471-6. PubMed ID: 1584324
[TBL] [Abstract][Full Text] [Related]
12. [The physiopathology of acute pancreatitis: the role of platelet-activating factor (PAF)].
Ais JG; Novo C; Gómez-Garre M; López-Farre A; López-Novoa JM; Romeo JM
Rev Esp Enferm Dig; 1992 Jan; 81(1):25-8. PubMed ID: 1547030
[TBL] [Abstract][Full Text] [Related]
13. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor.
Jancar S; De Giaccobi G; Mariano M; Mencia-Huerta JM; Sirois P; Braquet P
Prostaglandins; 1988 May; 35(5):757-70. PubMed ID: 2969600
[TBL] [Abstract][Full Text] [Related]
14. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis.
Sandoval D; Gukovskaya A; Reavey P; Gukovsky S; Sisk A; Braquet P; Pandol SJ; Poucell-Hatton S
Gastroenterology; 1996 Oct; 111(4):1081-91. PubMed ID: 8831604
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.
Stahl GL; Terashita Z; Lefer AM
J Pharmacol Exp Ther; 1988 Mar; 244(3):898-904. PubMed ID: 3252036
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2.
Takayasu M; Kondo K; Terao S
Biochem Biophys Res Commun; 1989 Apr; 160(2):751-7. PubMed ID: 2655596
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a PAF antagonist against liver injury induced by warm ischemia or cold preservation.
Wang KS; Monden M; Kanai T; Umeshita K; Ukei T; Nakano H; Gotoh M; Mori T
Transplant Proc; 1992 Aug; 24(4):1596-8. PubMed ID: 1496669
[No Abstract] [Full Text] [Related]
19. Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats.
Kitagawa S; Kubota Y; Yamaguchi T; Fujimura K; Binnaka T; Tani K; Ogura M; Mizuno T; Inoue K
J Gastroenterol Hepatol; 1992; 7(5):481-5. PubMed ID: 1391729
[TBL] [Abstract][Full Text] [Related]
20. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
